Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1224, 2000-01, pp. : 21-21
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Not all glitazones tarnished by hepatotoxicity?
Inpharma, Vol. 1, Iss. 1249, 2000-01 ,pp. :
Access to resources
Recommend
Hepatotoxicity with Thiazolidinediones: Is it a Class Effect?
By Scheen A.J.
Drug Safety, Vol. 24, Iss. 12, 2001-01 ,pp. :
Ramipril, rosiglitazone for atherosclerosis: STARR results?
Inpharma, Vol. 1, Iss. 1585, 2007-01 ,pp. :
Rosiglitazone and MI risk - will we ever know the answer?
Inpharma, Vol. 1, Iss. 1594, 2007-01 ,pp. :
Rosiglitazone: novel therapy for ulcerative colitis?
Inpharma, Vol. 1, Iss. 1322, 2002-01 ,pp. :